Medikamentenadhärenzstatistiken
Medication adherence — taking medications as prescribed — is one of the most researched yet least improved areas of healthcare. This page aggregates the most reliable statistics from WHO, CDC, NIH, and peer-reviewed studies.
Global Adhärenz Rates
WHO: Nur 50% der chronisch Kranken nehmen Medikamente wie verordnet.
Adhärenz by Condition
| Condition | Adhärenz Rate (1 Year) | Source |
|---|---|---|
| Hypertension | 50–60% | WHO, 2023 |
| Type 2 Diabetes | 45–55% | CDC, 2022 |
| Depression (antidepressants) | 40–50% | NIH, 2021 |
| Hyperlipidemia (statins) | 50–55% | AHA, 2022 |
| Asthma (controller meds) | 30–40% | NIH, 2020 |
| Antibiotika (full course) | 60–70% | CDC, 2023 |
Economic Impact
Die Adhärenz sinkt nach den ersten 6 Monaten erheblich. Nach einem Jahr nehmen nur noch 50% die Medikamente wie verordnet. MedPlanner hilft, die Gewohnheit aufrechtzuerhalten.
Mortality
An estimated 125,000 deaths per year in the United States are attributable to medication non-adherence — more than car accidents, breast cancer, and HIV/AIDS combined (CDC). This makes non-adherence the third-largest cause of preventable death after smoking and obesity.
Technology Impact on Adhärenz
- Simple reminder systems improve adherence by 20–40% (Cochrane Review, 2021).
- SMS reminders improve adherence by 15–25% for chronic conditions.
- Smartphone apps with confirmation tracking achieve 25–45% improvement.
- Betreuer involvement via technology adds an additional 10–15% improvement on top of reminders alone.
- Voice-based interfaces reduce setup time by 60% compared to form-based entry, lowering the barrier to adoption.
Why Adhärenz Drops Over Time
Die Adhärenz sinkt nach den ersten 6 Monaten erheblich: nur ~50% bleiben nach 1 Jahr adhärent. Regelmässige Erinnerungen helfen.
- Month 1: 75–85% adherence.
- Month 6: 55–65% adherence.
- Year 1: 45–55% adherence.
- Year 3+: 30–40% adherence.
Dieser Rückgang wird verursacht durch: Gewöhnung, fehlendes Feedback, Zeitmangel und komplexe Zeitpläne.
Quellen
- World Health Organization. "Adhärenz to Long-Term Therapies: Evidence for Action." 2023.
- CDC. "Medikamentenadhärenz: A Public Health Priority." 2022–2023.
- NIH. "Medikamentenadhärenz in Chronic Disease." National Institutes of Health, 2021.
- New England Healthcare Institute. "Thinking Outside the Pillbox." 2023.
- Cochrane Review. "Interventions for Enhancing Medikamentenadhärenz." 2021.
- American Heart Association. "Medikamentenadhärenz — Taking Your Meds as Directed." 2022.
- IQVIA Institute. "The Role of Digital Tools in Medikamentenadhärenz." 2023.